segment, Accredo Health Group. Medco, the world's most
advanced pharmacy(TM), is positioned to serve the unique needs of patients
with chronic and complex conditions through its Medco Therapeutic Resource
Centers(R), including its enhanced diabetes pharmacy care practice through
the Liberty acquisition. Medco is the highest-ranked independent pharmacy
benefit manager on the 2008 Fortune 100 list. On the Net:
http://www.medco.com.
This press release contains "forward-looking statements" as that term
is defined in the Private Securities Litigation Reform Act of 1995. These
statements involve risks and uncertainties that may cause results to differ
materially from those set forth in the statements. No forward-looking
statement can be guaranteed, and actual results may differ materially from
those projected. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information, future
events, or otherwise. Forward-looking statements in this press release
should be evaluated together with the risks and uncertainties that affect
our business, particularly those mentioned in the Risk Factors section of
the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q
filed with the Securities and Exchange Commission.
'/>"/>SOURCE Medco Health Solutions, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Medco Issues $1.5 Billion of Senior Notes2.
Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists3.
Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy4.
Medco to Webcast Annual Analyst Day Conference5.
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion6.
Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference7.
Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference8.
InterMune to Present at Deutsche Bank Health Care Conference9.
Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 200810.
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences11.
AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan